383 related articles for article (PubMed ID: 9326937)
21. Peptides from the PKD repeats of polycystin, the PKD1 gene product, modulate pattern formation in the developing kidney.
van Adelsberg J
Dev Genet; 1999; 24(3-4):299-308. PubMed ID: 10322638
[TBL] [Abstract][Full Text] [Related]
22. Altered Hippo signalling in polycystic kidney disease.
Happé H; van der Wal AM; Leonhard WN; Kunnen SJ; Breuning MH; de Heer E; Peters DJ
J Pathol; 2011 May; 224(1):133-42. PubMed ID: 21381034
[TBL] [Abstract][Full Text] [Related]
23. Molecular genetics and mechanism of autosomal dominant polycystic kidney disease.
Wu G; Somlo S
Mol Genet Metab; 2000 Jan; 69(1):1-15. PubMed ID: 10655152
[TBL] [Abstract][Full Text] [Related]
24. Autosomal dominant polycystic kidney disease: clinical and genetic aspects.
Sessa A; Ghiggeri GM; Turco AE
J Nephrol; 1997; 10(6):295-310. PubMed ID: 9442442
[TBL] [Abstract][Full Text] [Related]
25. Novel splicing and missense mutations in autosomal dominant polycystic kidney disease 1 (PKD1) gene: expression of mutated genes.
Aguiari G; Savelli S; Garbo M; Bozza A; Augello G; Penolazzi L; De Paoli Vitali E; La Torre C; Cappelli G; Piva R; del Senno L
Hum Mutat; 2000 Nov; 16(5):444-5. PubMed ID: 11058904
[TBL] [Abstract][Full Text] [Related]
26. PKD1 haploinsufficiency causes a syndrome of inappropriate antidiuresis in mice.
Ahrabi AK; Terryn S; Valenti G; Caron N; Serradeil-Le Gal C; Raufaste D; Nielsen S; Horie S; Verbavatz JM; Devuyst O
J Am Soc Nephrol; 2007 Jun; 18(6):1740-53. PubMed ID: 17475819
[TBL] [Abstract][Full Text] [Related]
27. The role of the polycystins in kidney development.
van Adelsberg JS
Pediatr Nephrol; 1999 Jun; 13(5):454-9. PubMed ID: 10412869
[TBL] [Abstract][Full Text] [Related]
28. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents.
Hanaoka K; Qian F; Boletta A; Bhunia AK; Piontek K; Tsiokas L; Sukhatme VP; Guggino WB; Germino GG
Nature; 2000 Dec 21-28; 408(6815):990-4. PubMed ID: 11140688
[TBL] [Abstract][Full Text] [Related]
29. Loss of heterozygosity in renal and hepatic epithelial cystic cells from ADPKD1 patients.
Badenas C; Torra R; Pérez-Oller L; Mallolas J; Talbot-Wright R; Torregrosa V; Darnell A
Eur J Hum Genet; 2000 Jul; 8(7):487-92. PubMed ID: 10909847
[TBL] [Abstract][Full Text] [Related]
30. Feline polycystic kidney disease mutation identified in PKD1.
Lyons LA; Biller DS; Erdman CA; Lipinski MJ; Young AE; Roe BA; Qin B; Grahn RA
J Am Soc Nephrol; 2004 Oct; 15(10):2548-55. PubMed ID: 15466259
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular polycystins: insights from autosomal dominant polycystic kidney disease and transgenic animal models.
Bichet D; Peters D; Patel AJ; Delmas P; Honoré E
Trends Cardiovasc Med; 2006 Nov; 16(8):292-8. PubMed ID: 17055386
[TBL] [Abstract][Full Text] [Related]
32. Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease.
Harris PC; Bae KT; Rossetti S; Torres VE; Grantham JJ; Chapman AB; Guay-Woodford LM; King BF; Wetzel LH; Baumgarten DA; Kenney PJ; Consugar M; Klahr S; Bennett WM; Meyers CM; Zhang QJ; Thompson PA; Zhu F; Miller JP
J Am Soc Nephrol; 2006 Nov; 17(11):3013-9. PubMed ID: 17035604
[TBL] [Abstract][Full Text] [Related]
33. A truncated polycystin-2 protein causes polycystic kidney disease and retinal degeneration in transgenic rats.
Gallagher AR; Hoffmann S; Brown N; Cedzich A; Meruvu S; Podlich D; Feng Y; Könecke V; de Vries U; Hammes HP; Gretz N; Witzgall R
J Am Soc Nephrol; 2006 Oct; 17(10):2719-30. PubMed ID: 16943309
[TBL] [Abstract][Full Text] [Related]
34. Co-inheritance of a PKD1 mutation and homozygous PKD2 variant: a potential modifier in autosomal dominant polycystic kidney disease.
Dedoussis GV; Luo Y; Starremans P; Rossetti S; Ramos AJ; Cantiello HF; Katsareli E; Ziroyannis P; Lamnissou K; Harris PC; Zhou J
Eur J Clin Invest; 2008 Mar; 38(3):180-90. PubMed ID: 18257781
[TBL] [Abstract][Full Text] [Related]
35. Common regulatory elements in the polycystic kidney disease 1 and 2 promoter regions.
Lantinga-van Leeuwen IS; Leonhard WN; Dauwerse H; Baelde HJ; van Oost BA; Breuning MH; Peters DJ
Eur J Hum Genet; 2005 May; 13(5):649-59. PubMed ID: 15770226
[TBL] [Abstract][Full Text] [Related]
36. [Mutational analysis of the PKD1 and PKD2 (type 1 and 2 dominant autosomal polycystic kidney) genes].
Torra R; Badenas C; Pérez-Oller L; San Millán JL; Tellería D; Estivill X; Darnell A
Nefrologia; 2000; 20(1):39-46. PubMed ID: 10822721
[TBL] [Abstract][Full Text] [Related]
37. Increased activity of activator protein-1 transcription factor components ATF2, c-Jun, and c-Fos in human and mouse autosomal dominant polycystic kidney disease.
Le NH; van der Wal A; van der Bent P; Lantinga-van Leeuwen IS; Breuning MH; van Dam H; de Heer E; Peters DJ
J Am Soc Nephrol; 2005 Sep; 16(9):2724-31. PubMed ID: 16049073
[TBL] [Abstract][Full Text] [Related]
38. Late onset of renal and hepatic cysts in Pkd1-targeted heterozygotes.
Lu W; Fan X; Basora N; Babakhanlou H; Law T; Rifai N; Harris PC; Perez-Atayde AR; Rennke HG; Zhou J
Nat Genet; 1999 Feb; 21(2):160-1. PubMed ID: 9988265
[No Abstract] [Full Text] [Related]
39. Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model.
Leonhard WN; van der Wal A; Novalic Z; Kunnen SJ; Gansevoort RT; Breuning MH; de Heer E; Peters DJ
Am J Physiol Renal Physiol; 2011 May; 300(5):F1193-202. PubMed ID: 21345977
[TBL] [Abstract][Full Text] [Related]
40. Autosomal dominant polycystic kidney disease: clues to pathogenesis.
Harris PC
Hum Mol Genet; 1999; 8(10):1861-6. PubMed ID: 10469838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
